
The team discovered that a cancer cell's ability to express Her2 receptors is dependent on the relative amounts of two proteins called Pax-2 and AIB-1. If Pax-2 is missing, or AIB-1 is present in large quantities, the cancer cell will activate Her2 and become resistant to tamoxifen.
This study is published in the 'Nature' journal.